Literature DB >> 2000940

Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds.

G F Pierce1, J Vande Berg, R Rudolph, J Tarpley, T A Mustoe.   

Abstract

Recombinant platelet-derived growth factor (PDGF) and transforming growth factor beta 1 (TGF-beta 1) influence the rate of extracellular matrix formed in treated incisional wounds. Because incisional healing processes are difficult to quantify, a full-thickness excisional wound model in the rabbit ear was developed to permit detailed analyses of growth-factor-mediated tissue repair. In the present studies, quantitative and qualitative differences in acute inflammatory cell influx, glycosaminoglycan (GAG) deposition, collagen formation, and myofibroblast generation in PDGF-BB (BB homodimer)- and TGF-beta 1-treated wounds were detected when analyzed histochemically and ultrastructurally. Although both growth factors significantly augmented extracellular matrix formation and healing in 10-day wounds compared with controls (P less than 0.002). PDGF-BB markedly increased macrophage influx and GAG deposition, whereas TGF-beta 1 selectively induced significantly more mature collagen bundles at the leading edge of new granulation tissue (P = 0.007). Transforming growth factor-beta 1-treated wound fibroblasts demonstrated active collagen fibrillogenesis and accretion of subfibrils at the ultrastructural level. Myofibroblasts, phenotypically modified fibroblasts considered responsible for wound contraction, were observed in control, but were absent in early growth-factor-treated granulating wounds. These results provide important insights into the mechanisms of soft tissue repair and indicate that 1) PDGF-BB induces an inflammatory response and provisional matrix synthesis within wounds that is qualitatively similar but quantitatively increased compared with normal wounds; 2) TGF-beta 1 preferentially triggers synthesis and more rapid maturation of collagen within early wounds; and 3) both growth factors inhibit the differentiation of fibroblasts into myofibroblasts, perhaps because wound contraction is not required, due to increased extracellular matrix synthesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2000940      PMCID: PMC1886289     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

1.  Effect of growth factors on hyaluronan synthesis in cultured human fibroblasts.

Authors:  P Heldin; T C Laurent; C H Heldin
Journal:  Biochem J       Date:  1989-03-15       Impact factor: 3.857

2.  Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability.

Authors:  R P Penttinen; S Kobayashi; P Bornstein
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

3.  A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta.

Authors:  P Rossi; G Karsenty; A B Roberts; N S Roche; M B Sporn; B de Crombrugghe
Journal:  Cell       Date:  1988-02-12       Impact factor: 41.582

4.  Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.

Authors:  S M Wahl; D A Hunt; L M Wakefield; N McCartney-Francis; L M Wahl; A B Roberts; M B Sporn
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  Platelet-derived growth factor promotes human peripheral monocyte activation.

Authors:  D Y Tzeng; T F Deuel; J S Huang; R L Baehner
Journal:  Blood       Date:  1985-07       Impact factor: 22.113

6.  Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta.

Authors:  C M Overall; J L Wrana; J Sodek
Journal:  J Biol Chem       Date:  1989-01-25       Impact factor: 5.157

7.  Transforming growth factor-beta. A very potent inhibitor of myoblast differentiation, identical to the differentiation inhibitor secreted by Buffalo rat liver cells.

Authors:  J R Florini; A B Roberts; D Z Ewton; S L Falen; K C Flanders; M B Sporn
Journal:  J Biol Chem       Date:  1986-12-15       Impact factor: 5.157

8.  Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells.

Authors:  E Van Obberghen-Schilling; N S Roche; K C Flanders; M B Sporn; A B Roberts
Journal:  J Biol Chem       Date:  1988-06-05       Impact factor: 5.157

9.  Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor.

Authors:  D R Edwards; G Murphy; J J Reynolds; S E Whitham; A J Docherty; P Angel; J K Heath
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

10.  Platelet-derived growth factor in chemotactic for fibroblasts.

Authors:  H Seppä; G Grotendorst; S Seppä; E Schiffmann; G R Martin
Journal:  J Cell Biol       Date:  1982-02       Impact factor: 10.539

View more
  50 in total

1.  Stricture formation in Crohn's disease: the role of intestinal fibroblasts.

Authors:  M C Regan; B M Flavin; J M Fitzpatrick; P R O'Connell
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Extraction and purification of TGFbeta and its effect on the induction of apoptosis of hepatocytes.

Authors:  X H Si; L J Yang
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

3.  The combined effects of TGF-beta, IGF and PDGF on 5alpha-reductase activity on androgen substrates in human gingival tissue.

Authors:  S C Kasasa; M Soory
Journal:  Inflammopharmacology       Date:  1998       Impact factor: 4.473

4.  In vivo responses of macrophages and myofibroblasts in the healing following isoproterenol-induced myocardial injury in rats.

Authors:  S Nakatsuji; J Yamate; M Kuwamura; T Kotani; S Sakuma
Journal:  Virchows Arch       Date:  1997-01       Impact factor: 4.064

5.  Selective deposits of versican in the extracellular matrix of restenotic lesions from human peripheral arteries.

Authors:  T N Wight; S Lara; R Riessen; R Le Baron; J Isner
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

6.  Expression of platelet-derived growth factor and its receptor in livers of patients with chronic liver disease.

Authors:  Y Ikura; H Morimoto; M Ogami; H Jomura; N Ikeoka; M Sakurai
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

7.  Smad3 signaling critically regulates fibroblast phenotype and function in healing myocardial infarction.

Authors:  Marcin Dobaczewski; Marcin Bujak; Na Li; Carlos Gonzalez-Quesada; Leonardo H Mendoza; Xiao-Fan Wang; Nikolaos G Frangogiannis
Journal:  Circ Res       Date:  2010-06-03       Impact factor: 17.367

8.  Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse.

Authors:  M Galeano; B Deodato; D Altavilla; D Cucinotta; N Arsic; H Marini; V Torre; M Giacca; F Squadrito
Journal:  Diabetologia       Date:  2003-04-02       Impact factor: 10.122

9.  Transforming growth factor beta 1-hyaluronic acid interaction.

Authors:  P Locci; L Marinucci; C Lilli; D Martinese; E Becchetti
Journal:  Cell Tissue Res       Date:  1995-08       Impact factor: 5.249

10.  Tissue repair processes in healing chronic pressure ulcers treated with recombinant platelet-derived growth factor BB.

Authors:  G F Pierce; J E Tarpley; R M Allman; P S Goode; C M Serdar; B Morris; T A Mustoe; J Vande Berg
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.